INTRODUCTION
eriodic Rift Valley fever (RVF) outbreaks in livestock (goats, sheep, cattle, and camels) and acute febrile illness with hemorrhagic syndrome in humans have been reported widely throughout south and central Africa, from Kenya westward into Nigeria, Niger, Burkina Faso, Senegal, and Mauritania and northward into Egypt (Diallo et al., 2005) . RVF virus, a Phlebovirus from the family Bunyaviridae, is potentially transmitted by many different species of insect vectors that have a wide global distribution (Gubler, 2002) . To limit spread of the disease, veterinary vaccines are the first line of defense against RVF virus infection. Extensive work has been carried out to produce safe and efficient vaccines against Rift Valley Fever (Kamal, 2011) . A trial for preparing a potent and safe inactivated vaccine to be used for the spreading of the disease was attempted (Abd El Samea et al., 1994 , El-Bagoury et al., 2013 . Two types of inactivated RVF vaccines were produced in Egypt; first produced by VACSERA company which is formalin inactivated and alum adjuvanted (Menya/Sheep/258), and the second produced by the Veterinary Serum and Vaccine Research Institute (VSVRI) which is binary ethylenimine (BEI) inactivated and alum hydroxide adjuvanted (ZH501strain) (El-Nimr 1980) and (Eman 1995) . The present trend in the development of new vaccines focuses on simplification of vaccination schemes either by increasing the components in the vaccines or by decreasing the number of vaccination doses needed to impart sufficient protection. One of the possibilities how to achieve this goal is the P BENHA VETERINARY MEDICAL JOURNAL, VOL. 29, NO. 1:224-228, SEPTEMBER, 2015 use of new, more effective adjuvants. Adjuvant substances have been used for almost 80 years for increasing the effectiveness of various vaccines (Ramon, 1925) . For a long time, oil adjuvants based on incomplete Freund's adjuvant played an important role in commercial veterinary vaccines. However, the mineral oil used caused various post-vaccination reaction of local or even general character in vaccinated individuals (Vanselow, 1987) . At the present time aluminium hydroxide is the substance most frequently used as adjuvant in veterinary medicine (Clements and Griffiths, 2002) 
MATERIAL AND METHODS

2.1.
Virus strain RVF virus Zagazig Human 501 (ZH501) strain was propagated in BHK-21 cell line of a titer 107.5 TCID50/ ml was supplied by RVF Department, Veterinary Serum and Vaccine Research Institute, Abbasia, Cairo. It was used for preparation of inactivated vaccine, SNT and ELISA.
Cell lines
Baby hamster kidney (BHK-21) cell line was established by Mackpherson and Stocker, 1962 . They were used for propagation, titration of the virus and testing the safety of prepared inactivated virus suspension.
Animals
Mice
Forty five Albino Swiss mice, 3-4 weeks old, were supplied by the Department of Pet Animal vaccine Research; Veterinary Serum and Vaccine Research Institute; Abassia, Cairo. These mice were used in toxicity test to determine safe concentration of oil adjuvants.
Sheep and experimental design
Twenty four local breed sheep 3-4 month old were used for evaluation of their immune response to the prepared vaccines. All of these animals were screened using SNT and proved to be free from RVF antibodies, the sheep were divided into 4 groups as follows:-Group 1(G1): six animals, each vaccinated subcutaneously (S/C) with 1ml of inactivated Montanide oil ISA 61 RVF vaccine.
Group 2(G2): six animals, each vaccinated subcutaneously (S/C) with 1ml of inactivated Montanide oil ISA 201 RVF vaccine.
Group 3(G3): six animals, each vaccinated subcutaneously (S/C) with 1ml of inactivated aluminium hydroxide gel compound RVF vaccine.
Group 4 (G4): six animals kept as non vaccinated (control negative).
2.4.
Samples collection All sera were collected from groups 1, 2, 3, 4 on the day of vaccination (zero day), then weekly till 4th week post vaccination and monthly till protective antibody level declined. The sera were stored at -20°C and inactivated at 56°C for 30 minutes before being examined by the Serum Neutralization Test (SNT) and indirect enzyme-linked immunosorbent assay (ELISA). 
2.5.Adjuvants
2.6.Serum neutralization test (SNT)
It was performed using the micro technique as described formerly (Ramon G. 1925) .
2.7.Enzyme-linked immunosorbent assay (ELISA)
It was carried out according to earlier author (Randall et.al. 1964 ) to determine antibodies against RVF virus using ELISA.
RESULTS
3.1.Sterility test
Inactivated vaccines were sterile as they were free from any bacterial and fungal contaminants.
3.2.Safety test of inactivated RVFV in baby mice
Inactivated vaccines were safe. No mortality occurred indicates optimum inactivation process. RVF virus antibodies titer expressed with the optical density in sera of vaccinated sheep as observed by ELISA found parallel to preceding result in SNT. 
3.3.Humoral immune response in sheep vaccinated with inactivated RVF virus vaccines
DISCUSSION
The Egyptian veterinary researchers succeeded in preparing a save and potent alum adjuvant inactivated RVF vaccine to protect sheep and cattle against the disease [5] .
The experimental results revealed that all prepared vaccine formula were free from foreign contaminants (aerobic and anaerobic bacteria; fungi and mycoplasma) and safe in vaccinated animals where such animals remained healthy all over the experimental period without local reaction at the site of inoculation. These observations agree with the recommendations of (USA-CER 1987). Also Gupta et al., 1993 showed that an adjuvant should stimulate high antibody titers, but in the process it should have low toxicity and not induce harmful side effects after injection
Results of SNT and ELISA were coming in a parallel manner confirming each other. In conclusion, results gave the priority to the prepared inactivated Montanide oil ISA61 RVF vaccine and inactivated Montanide oil ISA201 RVF vaccine over the local inactivated aluminum hydroxide gel adjuvanted RVF vaccine beside that RVF vaccine with Montanide oil ISA201 induces rapid onset immunological response with long duration (El-Bagoury et al., 2013) .
Higher SNT titer and ELISA optical density reported that oil based RVF virus vaccines compared with that of aluminum hydroxide gel containing vaccines could be explained by the relatively rabid release of the antigen from the gel material in comparing with that in oil adjuvant trapped by oil environment (Jansen et al., 2005) .
On the other hand Montanide oil ISA 206 induced the highest and the probably longest immunity as stated by Fatthia, 2003 and Sonia, 2007 as this adjuvant improves and enhance both cell mediated and humoral immune response (Aucouturier et al 2006 , El-Bagoury et al., 2013 These adjuvants are patent contain its own surfactant which enable an easy manufacturing of vaccines by mixing the aqueous medium into the montanide oil at room temperature.
